Stock ENDV ENDONOVO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Endonovo Therapeutics, Inc. Other OTC

Equities

ENDV

US29272H3003

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg
AQ
Endonovo Therapeutics, Inc. Appoints Ira Weisberg President to Guide Global Medical Expansion
CI
Endonovo Therapeutics Inc. Appoints Garry Michael Kann as Head of Corporate Development
CI
Endonovo Therapeutics, Inc. Announces Resignation of Michael Mann as President
CI
Endonovo Therapeutics, Inc. Appoints William Li as Strategic Advisor to the CEO
CI
Endonovo Appoints Samir Awad, M.D., to Scientific Advisory Board
CI
Endonovo Therapeutics Appoints Geoffrey Abrams to its Scientific Advisory Board
CI
Endonovo Therapeutics, Inc. Appoints Peter Novak to Scientific Advisory Board
CI
Endonovo Therapeutics Appoints Steven Levin of Johns Hopkins University to Its Scientific Advisory Board
CI
Roc Alan McCarthy Joins Endonovo Therapeutics, Inc. as Scientific Advisory Board Member
CI
Endonovo Therapeutics, Inc. Appoints Nevena Zubcevik as Chief Medical Officer, Effective July 1, 2019
CI
Endonovo Therapeutics, Inc. Appoints Randolph M. Johnson as Executive Vice President, Clinical Development and Chief Development Officer
CI
Endonovo Therapeutics, Inc. Appoints Leonard Makowka as Chief Medical Officer; to Develop Next Generation, Off-The-Shelf, Cell Free Regenerative Products
CI
Hanover Portfolio Acquisitions, Inc. has Changed its Name to Endonovo Therapeutics
CI
Hanover Portfolio Acquisitions, Inc. Appoints Donnie Rudd as Director of Intellectual Property
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENDV Stock
  4. ENDV Stock
  5. News Endonovo Therapeutics, Inc.
  6. Insiders